| http://www.w3.org/ns/prov#value | - When the cell is exposed to an anti-AAH antibody in vivo, the methods can be described as methods for treating a patient who has a disorder (e.g., a cancer or other disorder of unwanted cellular proliferation) or who is a risk for developing such a disorder (e.g., a patient in which AAH is overactive or overexpressed but who does not yet have a detectable tumor or other sign of cancer).
|
